Medical Monday: Cashing In On Synthetic Cannabis

A liquid synthetic THC formulation of dronabinol has just been approved by the Federal Drug Administration and is now available to medical cannabis patients, under the name Syndros. And guess what, it’s Schedule III.

Dronabinol, the generic name for the brand name Marinol, was approved by the FDA as an oral pill in 1985. Marinol is classified as a Schedule III controlled substance under the Controlled Substances Act. Syndros, the new liquid form, created by the pharmaceutical company Insys Therapeutics, is as well. Yes, Dronabinol was also developed by the same company. (Cha-ching!)

Marinol has been commonly prescribed for those seeking an increase in appetite and a decrease in vomiting, due to the effects of chemotherapy and AIDS.

Dr. William Eidelman, a pioneer of medical cannabis with an office in Hollywood, California has been prescribing Marinol to patients for years.

“Some of my patients like Marinol and some don’t,” explained Eidelman to DOPE Magazine.

... read more at: http://www.dopemagazine.com/medical-monday-cashing-in-on-synthetic-cannabis/

Medical Monday: Cashing In On Synthetic Cannabis

A liquid synthetic THC formulation of dronabinol has just been approved by the Federal Drug Administration and is now available to medical cannabis patients, under the name Syndros. And guess what, it’s Schedule III.

Dronabinol, the generic name for the brand name Marinol, was approved by the FDA as an oral pill in 1985. Marinol is classified as a Schedule III controlled substance under the Controlled Substances Act. Syndros, the new liquid form, created by the pharmaceutical company Insys Therapeutics, is as well. Yes, Dronabinol was also developed by the same company. (Cha-ching!)

Marinol has been commonly prescribed for those seeking an increase in appetite and a decrease in vomiting, due to the effects of chemotherapy and AIDS.

Dr. William Eidelman, a pioneer of medical cannabis with an office in Hollywood, California has been prescribing Marinol to patients for years.

“Some of my patients like Marinol and some don’t,” explained Eidelman to DOPE Magazine.

... read more at: http://www.dopemagazine.com/medical-monday-cashing-in-on-synthetic-cannabis/